EPAS1 trans-activation during hypoxia requires p42/p44 MAPK

Area of Science:

• Molecular Biology
• Cellular Signaling
• Hypoxia Research

Background:

• Hypoxia is a significant environmental stress impacting gene expression and cellular functions.
• Several hypoxia-regulated transcription factors mediate cellular responses, including EPAS1 (Endothelial PAS-domain Protein 1).
• The specific signaling pathways governing EPAS1 activation remained largely unknown.

Purpose of the Study:

• To elucidate the signaling pathways responsible for EPAS1 activation under hypoxic conditions.
• To investigate the role of MAPK and Ras pathways in EPAS1 activation.

Main Methods:

• Utilized PC12 cells exposed to hypoxia.
• Employed MEK inhibitor PD98059 to block MAPK activity.
• Assessed EPAS1 phosphorylation and trans-activation of a hypoxia response element (HRE) reporter gene.
• Investigated the role of Ras and calmodulin using specific inhibitors and activators.

Main Results:

• Hypoxia induces EPAS1 phosphorylation, critically mediated by p42/p44 MAPK.
• MEK inhibition blocked EPAS1 trans-activation but not phosphorylation, indicating MAPK acts downstream of phosphorylation.
• EPAS1 activation by hypoxia is independent of Ras.
• Calmodulin antagonists significantly inhibited both MAPK phosphorylation and EPAS1 trans-activation.

Conclusions:

• The MAPK pathway is essential for EPAS1 activation during hypoxia.
• EPAS1 activation involves a calmodulin-sensitive pathway, distinct from Ras-mediated signaling.
• This study identifies a specific signaling cascade regulating EPAS1 activity under hypoxic stress.